Gene · 5921
Papers3,549
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
261 to 280 of 3,549
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Molecular characterization of colorectal adenoma and colorectal cancer via integrated genomic transcriptomic analysis. | Front Oncol | 2023 | 37546388 | PubTator, text mining | PubMed |
| Ligand-independent activation of platelet-derived growth factor receptor β promotes vitreous-induced contraction of retinal pigment epithelial cells. | BMC Ophthalmol | 2023 | 37537538 | PubTator, text mining | PubMed |
| An intellectual-disability-associated mutation of the transcriptional regulator NACC1 impairs glutamatergic neurotransmission. | Front Mol Neurosci | 2023 | 37533751 | PubTator, text mining | PubMed |
| RASopathies and cardiac manifestations. | Front Cardiovasc Med | 2023 | 37529712 | PubTator, text mining | PubMed |
| Phosphoinositides and intracellular calcium signaling: novel insights into phosphoinositides and calcium coupling as negative regulators of cellular signaling. | Exp Mol Med | 2023 | 37524877 | PubTator, text mining | PubMed |
| Network embedding framework for driver gene discovery by combining functional and structural information. | BMC Genomics | 2023 | 37516822 | PubTator, text mining | PubMed |
| The DUSP domain of pseudophosphatase MK-STYX interacts with G3BP1 to decrease stress granules. | Arch Biochem Biophys | 2023 | 37516290 | PubTator, text mining | PubMed |
| Pan-tumor survey of RET fusions as detected by next-generation RNA sequencing identified RET fusion positive colorectal carcinoma as a unique molecular subset. | Transl Oncol | 2023 | 37516008 | PubTator, text mining | PubMed |
| Integrative Multi-Omics Analysis of Oncogenic EZH2 Mutants: From Epigenetic Reprogramming to Molecular Signatures. | Int J Mol Sci | 2023 | 37511137 | PubTator, text mining | PubMed |
| Diverse p120RasGAP interactions with doubly phosphorylated partners EphB4, p190RhoGAP, and Dok1. | J Biol Chem | 2023 | 37507023 | PubTator, text mining | PubMed |
| Effects of Ayurveda interventions on acute pain and quality of life of a trigeminal neuralgia patient - A case report. | J Ayurveda Integr Med | 2023 | 37494834 | PubTator, text mining | PubMed |
| Plasmapheresis to remove amyloid fibrin(ogen) particles for treating the post-COVID-19 condition. | Cochrane Database Syst Rev | 2023 | 37491597 | PubTator, text mining | PubMed |
| Targeting miRNA and using miRNA as potential therapeutic options to bypass resistance in pancreatic ductal adenocarcinoma. | Cancer Metastasis Rev | 2023 | 37490255 | PubTator, text mining | PubMed |
| Hax1 regulate focal adhesion dynamics through IQGAP1. | Cell Commun Signal | 2023 | 37488602 | PubTator, text mining | PubMed |
| Management of allergic rhinitis with Rajanyadi Churna and Guduchi Kwatha- A case report. | J Ayurveda Integr Med | 2023 | 37478634 | PubTator, text mining | PubMed |
| Comprehensive analysis of the progression mechanisms of CRPC and its inhibitor discovery based on machine learning algorithms. | Front Genet | 2023 | 37476415 | PubTator, text mining | PubMed |
| Distinct shared and compartment-enriched oncogenic networks drive primary versus metastatic breast cancer. | Nat Commun | 2023 | 37463901 | PubTator, text mining | PubMed |
| Oncogenic Drivers and Therapeutic Vulnerabilities in KRAS Wild-Type Pancreatic Cancer. | Clin Cancer Res | 2023 | 37463056 | PubTator, text mining | PubMed |
| Long non-coding RNAs in non-small cell lung cancer: implications for EGFR-TKI resistance. | Front Genet | 2023 | 37456663 | PubTator, text mining | PubMed |
| Delineation of the phenotypes and genotypes of facial infiltrating lipomatosis associated with PIK3CA mutations. | Orphanet J Rare Dis | 2023 | 37452404 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5921/papers?page=14